← Open Payments lookup

SANDRINE MOTOKWA NTSANG: Open Payments

NPI 1023710704 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,081 in 87 payments from 13 companies in 2025. Trend: 2023 $2,459 · 2024 $3,615 · 2025 $2,081

Food & beverage: $2,072Education: $10
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.18$593
ABBVIE INC.26$430
Axsome Therapeutics, Inc.9$218
Alkermes, Inc.7$189
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$160
E.R. Squibb & Sons, L.L.C.3$146
Lundbeck LLC4$82
Vanda Pharmaceuticals Inc.3$58
Takeda Pharmaceuticals U.S.A., Inc.3$57
Almatica Pharma LLC3$55

Products named: REXULTI, VRAYLAR, Auvelity, CAPLYTA, LYBALVI, COBENFY, FANAPT, TRINTELLIX.

Industry payments across TX — which companies pay providers there.